Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$204.38 - $296.82 $580,234 - $842,671
-2,839 Reduced 3.61%
75,889 $15.6 Million
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $15.4 Million - $24.4 Million
78,728 New
78,728 $21.9 Million
Q1 2022

May 16, 2022

SELL
$127.96 - $207.36 $783,115 - $1.27 Million
-6,120 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$165.13 - $241.83 $756,130 - $1.11 Million
4,579 Added 297.14%
6,120 $1.09 Million
Q3 2021

Nov 15, 2021

BUY
$163.99 - $235.57 $252,708 - $363,013
1,541 New
1,541 $317,000
Q2 2021

Aug 16, 2021

SELL
$131.45 - $201.49 $407,494 - $624,619
-3,100 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$92.73 - $142.05 $287,463 - $440,355
3,100 New
3,100 $404,000
Q4 2020

Feb 16, 2021

SELL
$67.44 - $103.72 $695,306 - $1.07 Million
-10,310 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$42.79 - $75.8 $441,164 - $781,498
10,310 New
10,310 $781,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Quadrature Capital LTD Portfolio

Follow Quadrature Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quadrature Capital LTD with notifications on news.